Showing results (1981-1990 of 31,409) with videos related to
Sort By:
Pageof 3,141
Journal of Medicinal Chemistry|January 7, 1994
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclinesP E Sum, V J Lee, R T Testa, et al.Journal of Medicinal Chemistry|January 7, 1994
Enhancement of iron excretion via monoanionic 3-hydroxypyrid-4-onesJ J Molenda, M M Jones, M A BasingerJournal of Medicinal Chemistry|June 23, 1995
Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activityM Alam, V Zhestkov, B P Sani, et al.Journal of Medicinal Chemistry|June 23, 1995
Mechanism-based development of new antimalarials: synthesis of derivatives of artemisinin attached to iron chelatorsS Kamchonwongpaisan, S Paitayatat, Y Thebtaranonth, et al.Journal of Medicinal Chemistry|June 23, 1995
Sequence-dependent drug binding to the minor groove of DNA: crystal structure of the DNA dodecamer d(CGCAAATTTGCG)2 complexed with propamidineC M Nunn, S NeidleJournal of Medicinal Chemistry|June 23, 1995
Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequenceS Arttamangkul, T F Murray, G E DeLander, et al.Journal of Medicinal Chemistry|June 23, 1995
Synthesis and activity against multidrug resistance in Chinese hamster ovary cells of new acridone-4-carboxamidesN Dodic, B Dumaitre, A Daugan, et al.Journal of Medicinal Chemistry|September 15, 1995
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.Journal of Medicinal Chemistry|September 15, 1995
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivativesR C Schnur, M L Corman, R J Gallaschun, et al.Journal of Medicinal Chemistry|September 15, 1995
Quantitative structural activity relationship study of bis-tetraazacyclic compounds. A novel series of HIV-1 and HIV-2 inhibitorsH C Joao, K De Vreese, R Pauwels, et al.Pageof 3,141